19.10.2017
- A lawsuit filed in the US capital of Washington, DC this week alleges that bribes it says were paid by leading drugmakers including Pfizer, Roche, Johnson & Johnson and AstraZeneca...
13.10.2017
- Pfizer is reviewing the future of its Consumer Healthcare division. The US drug major said it is considering a range of options, including a full or partial separation through a...
03.10.2017
- Pfizer is suing Johnson & Johnson (J&J) in the US over what it terms anti-competitive practices against its biosimilar Inflectra. The lawsuit is said to be the first of its kind...
07.09.2017
- Germany’s Merck KGaA is weighing options for its Consumer Health business, which it says has a strong market position but needs more investment to grow sufficiently. The chemicals...
25.08.2017
- The Janssen unit of Johnson & Johnson has hit out at plans by the US state of Florida to execute a death row prisoner using an experimental lethal injection that contains an active...
05.07.2017
- Merck Ventures, the strategic investment arm of German pharmaceuticals and life sciences group Merck KGaA, has created immuno-oncology company iOnctura. Based in Geneva...
16.05.2017
- Major US drugmaker Pfizer is collaborating with Sangamo Therapeutics to develop and commercialize gene therapy programs for the rare blood disorder hemophilia A. The agreement...
09.05.2017
- For as much as five months, US drugmaker Pfizer will provide its breast cancer drug palbociclib for free to the England arm of the UK’s National Health Service (NHS). The decision...
